Profile
SXTP VRTX ALNY REGN ARGX SGEN
Company Name 60 Degrees Pharmaceuticals, Inc. Vertex Pharmaceuticals Incorporated Alnylam Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc. argenx SE Seagen Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $5.19M $100.41B $60.32B $58.82B $48.74B $43.15B
Employees 0.00K 6.10K 2.23K 15.16K 1.60K 3.26K
CEO Geoffrey Stuart Dow Reshma Kewalramani FASN, Yvonne L. Greenstreet Leonard S. Schleifer Timothy Van Hauwermeiren EMBA, David R. Epstein
Ratings
SXTP VRTX ALNY REGN ARGX SGEN
Quant Rating Score 2 3 1 4 3 3
Quant Rating Sell Neutral Strong Sell Buy Neutral Neutral
Trading
SXTP VRTX ALNY REGN ARGX SGEN
Last Close $1.8 $412.22 $469.36 $572.6 $812.95 $228.74
High 52 $3.45 $516.74 $482.13 $1016.53 $812.95 $228.74
Low 52 $0.45 $366.54 $224.58 $482.92 $532.27 $228.74
Price vs. 52 Week High -47.83 % -20.23 % -2.65 % -43.67 % 0 % 0 %
Price vs. 52 Week Low 300 % 12.46 % 108.99 % 18.57 % 52.73 % 0 %
Total Return
SXTP VRTX ALNY REGN ARGX SGEN
1 Month Return 31.39 % 4.83 % 1.78 % -0.02 % 7.44 % 0 %
3 Month Return 2.86 % -11.2 % 50.83 % 4.52 % 46.45 % 0 %
6 Month Return -47.83 % -17.64 % 103.34 % 2.63 % 34.36 % 0 %
9 Month Return 98.9 % -2.84 % 86.99 % -18.6 % 22.21 % 0 %
YTD Return 39.53 % 2.36 % 99.46 % -19.62 % 32.19 % 0 %
1 Year Return 89.47 % -14.88 % 63.34 % -43.67 % 49.24 % 0 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
SXTP VRTX ALNY REGN ARGX SGEN
Dividend Yield Percentage (TTM) - - - 0.47 % - -
Dividend Paid and Capex Coverage Ration (TTM) -81.48 % 11.09 % -0.43 % 4.37 % 65.28 % -5.87 %
Dividend Per Share (TTM) - - - 2.64 % - -
Payout Ratio (TTM) - - - 4.18 % - -
Profitability
SXTP VRTX ALNY REGN ARGX SGEN
Gross Profit Margin TTM 28.88 % 86.11 % 83.64 % 81.98 % 65.82 % 79.1 %
Return on Assets TTM -186.47 % 15.13 % -6.99 % 11.67 % 15.06 % -16.61 %
Return on Equity TTM -187.75 % 22.14 % -274.21 % 15.11 % 18.96 % -20.8 %
Return on Capital Employed TTM -309.5 % 19.72 % -5.52 % 11.45 % 5.04 % -21.46 %
Net Income Per EBT TTM 99.71 % 83.16 % 84.06 % 91.46 % 237.3 % 101.33 %
EBT Per Ebit TTM 101.43 % 111.48 % 210.66 % 123.23 % 147.38 % 98.26 %
EBIT Per Revenue TTM -802.41 % 34.36 % -7.32 % 27.83 % 13.47 % -31.24 %
Cash Flow To Debt Ratio TTM -2152 % 251.83 % -1.2 % 175.35 % 932.29 % -1043.73 %
Receivables Turnover TTM 3.26 6.03 4.34 2.53 1.91 3.91
Payables Turnover TTM 0.39 3.59 3.93 3.54 0.9 1.97
Inventory Turnover TTM 0.44 1.06 5.62 0.8 2.26 0.96
Fixed Asset Turnover TTM 495.61 % 431.08 % 355.68 % 293.64 % 5009.77 % 665.41 %
Asset Turnover TTM 22.98 % 47.51 % 53.92 % 37.19 % 31.97 % 53.41 %
Operating Cash Flow Per Share TTM -2.25 14.98 -0.12 45.13 5.67 -2.46
Free Cash Flow Per Share TTM -2.28 13.63 -0.4 36.58 5.58 -2.88
Cash Per Share TTM 133.54 % 2486.48 % 2203.63 % 7107.14 % 5536.58 % 939.52 %
Operating Cash Flow Sales Ratio TTM -345.46 % 33.68 % -0.63 % 33.37 % 17.54 % -23.12 %
Free Cash Flow Operating Cash Flow Ratio TTM 101.23 % 90.99 % 335.21 % 81.05 % 98.47 % 117.04 %
Cash Flow Coverage Ratios TTM -2152 % 251.83 % -1.2 % 175.35 % 932.29 % -1043.73 %
Price To Free Cash Flows Ratio TTM -1.55 28.69 -1157.98 15.3 123.13 -81.26
Price To Operating Cash Flows Ratio TTM -0.71 26.14 -3840.08 12.51 140.63 -93.1
Price Cash Flow Ratio TTM -0.71 26.14 -3840.08 12.51 140.63 -93.1
Income Statement (TTM)
SXTP VRTX ALNY REGN ARGX SGEN
Revenue $0B $11.02B $2.25B $14.2B $2.19B $1.96B
Gross Profit $0B $9.49B $1.92B $11.75B $1.96B $1.55B
Gross Profit Ratio 32.7% 86.11% 85.62% 82.74% 89.62% 79.1%
EBITDA $-0.01B $0.49B $-0.18B $5.32B $0.11B $-0.62B
Net Income $-0.01B $-0.54B $-0.28B $4.41B $0.83B $-0.61B
EPS Diluted -18.55 -2.08 -2.16 38.34 12.78 -3.3
Balance Sheet (MRQ)
SXTP VRTX ALNY REGN ARGX SGEN
Long Term Debt $0B $1.66B $1.25B $2.7B $0.03B $0.04B
Total Liabilities $0B $6.12B $4.17B $8.41B $0.7B $0.87B
Total Equity $0B $16.41B $0.07B $29.35B $5.5B $2.8B
Total Investments $0B $6.65B $1.73B $15.42B $1.93B $1.42B
Total Debt $0B $1.75B $1.3B $2.7B $0.04B $0.04B
Total Assets $0.01B $22.53B $4.24B $37.76B $6.2B $3.67B
Cash Flow Statement (TTM)
SXTP VRTX ALNY REGN ARGX SGEN
Net Income $-0.01B $-0.54B $-0.28B $4.41B $0.83B $-0.61B
Inventory $0B $-0.52B $0.01B $-0.62B $-0.1B $-0.23B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.01B $-0.49B $-0.01B $4.42B $-0.08B $-0.45B
Capital Expenditure $-0B $-0.3B $-0.03B $-0.76B $-0.07B $-0.08B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 36.72
AARD Aardvark Therapeutics, Inc. Common Stock 13.96
ABCL AbCellera Biologics Inc. 6.095
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.54
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.29
ABPWW 0.0324
ABSI Absci Corporation 4.995
ABUS Arbutus Biopharma Corporation 4.48
ABVC ABVC BioPharma, Inc. 2.892
ABVX Abivax SA American Depositary Shares 95.745
ACAD ACADIA Pharmaceuticals Inc. 21.735
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.9842
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 3.185
ACIU AC Immune SA 3.078
ETFs With Exposure to SXTP
Ticker ETF Name Weight Percentage Price
VXF Vanguard Extended Market Index Fund 0 212.615
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 160.36
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 160.38
VEMPX Vanguard Extended Market Index InstlPlus 0 395.75
Unlock